Brought to you by IBM
- Insurance 2020: Innovating beyond old models
- Insurance 2020: Now what?
- Customer advocates: Your most valuable asset
- IBM and Cisco front office solutions for retail banking
- Opening act - Streamlining a bank's account-opening process can have a dramatic effect on customer experience and the bottom line
- The Agile CFO; Enabling the innovation path to growth
- The Evolution of Asset Mangement
- The Global CFO Study 2008
- Thinking Through Uncertainty: CFOs scrutinize Non-Financial Risk
Most Popular White Papers
Think what's possible.(profile of Novartis AG)(Company Profile)(Advertisement)
Research, March, 2003
Tags: advertisement, Novartis AG
ovartis AG
(NYSE: NVS) is a world leader in pharmaceuticals and consumer health. In 2002, the Group's businesses achieved sales of CHF 32.4 billion (USD 20.9 billion) and a net income of CHF 7.3 billion (USD 4.7 billion). The Group invested approximately CHF 4.3 billion (USD 2.8 billion) in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ about 72,900 people and operate in over 140 countries around the world.
Recent Highlights
* Launched ZELNORM[TM] (tegaserod maleate) in the US for treatment of irritable bowel syndrome with constipation in women. ...
Read the rest of this article with a Free Trial at HighBeam Research.
